Wellington Management Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.3M | Buy |
1,229,599
+16,560
| +1% | +$596K | 0.01% | 719 |
|
2025
Q1 | $47.8M | Buy |
1,213,039
+1,149,526
| +1,810% | +$45.3M | 0.01% | 692 |
|
2024
Q4 | $1.91M | Sell |
63,513
-9,807
| -13% | -$295K | ﹤0.01% | 1566 |
|
2024
Q3 | $1.71M | Buy |
73,320
+8,249
| +13% | +$193K | ﹤0.01% | 1569 |
|
2024
Q2 | $1.16M | Sell |
65,071
-3,088,522
| -98% | -$54.9M | ﹤0.01% | 1633 |
|
2024
Q1 | $48M | Buy |
3,153,593
+13,829
| +0.4% | +$210K | 0.01% | 715 |
|
2023
Q4 | $53.6M | Buy |
3,139,764
+43,290
| +1% | +$739K | 0.01% | 690 |
|
2023
Q3 | $25.9M | Sell |
3,096,474
-63,138
| -2% | -$528K | 0.01% | 891 |
|
2023
Q2 | $78.5M | Sell |
3,159,612
-168,739
| -5% | -$4.19M | 0.01% | 604 |
|
2023
Q1 | $50.1M | Sell |
3,328,351
-105,099
| -3% | -$1.58M | 0.01% | 692 |
|
2022
Q4 | $40.6M | Sell |
3,433,450
-988,672
| -22% | -$11.7M | 0.01% | 736 |
|
2022
Q3 | $26.2M | Buy |
4,422,122
+234,678
| +6% | +$1.39M | 0.01% | 838 |
|
2022
Q2 | $17.8M | Buy |
4,187,444
+166,968
| +4% | +$710K | ﹤0.01% | 969 |
|
2022
Q1 | $38.2M | Sell |
4,020,476
-230,194
| -5% | -$2.19M | 0.01% | 840 |
|
2021
Q4 | $80.8M | Buy |
4,250,670
+2,674,941
| +170% | +$50.8M | 0.01% | 686 |
|
2021
Q3 | $52.4M | Sell |
1,575,729
-2,671,948
| -63% | -$88.9M | 0.01% | 804 |
|
2021
Q2 | $165M | Sell |
4,247,677
-69,084
| -2% | -$2.68M | 0.03% | 489 |
|
2021
Q1 | $208M | Sell |
4,316,761
-601,072
| -12% | -$29M | 0.04% | 417 |
|
2020
Q4 | $256M | Buy |
4,917,833
+1,610,787
| +49% | +$83.8M | 0.05% | 351 |
|
2020
Q3 | $88.5M | Buy |
+3,307,046
| New | +$88.5M | 0.02% | 551 |
|
2018
Q2 | – | Sell |
-106,021
| Closed | -$1.51M | – | 2314 |
|
2018
Q1 | $1.51M | Buy |
+106,021
| New | +$1.51M | ﹤0.01% | 1810 |
|